See the latest Coronavirus Information including testing sites, visitation restrictions, appointments and scheduling, and more.
Validated outcome measures have an important role in standardizing patient care and in developing reliable clinical trials by objectively measuring the severity of disease. The following tools have been developed by the Autoimmune Skin Disease Study Unit to assess cutaneous disease activity and damage in autoimmune skin diseases.
The tools and teaching slides are available for licensing for pharmaceutical sponsored clinical trials or for academic/clinical use by contacting the Penn Center for Innovation at 215-573-4307 or email email@example.com. We will register you as a licensee and will provide the CLASI tool as a form.